114 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: Mammosite ML
22 Recruiting Plasma Biomarkers P-DAC, V1
Condition: Pancreatic Ductal Adenocarcinoma
23 Recruiting Intraoperative Imaging of Breast Cancer With Indocyanine Green
Conditions: Invasive Ductal Carcinoma;   Invasive Lobular Carcinoma;   Ductal Carcinoma
Intervention: Drug: Indocyanine Green
24 Recruiting Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: PTP-01
25 Recruiting Broccoli Sprout Extract in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma;   Ductal Breast Carcinoma In Situ;   Estrogen Receptor Negative;   Estrogen Receptor Positive;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma;   Postmenopausal;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Broccoli Sprout Extract;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo
26 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
27 Recruiting A Phase II Study of Neoadjuvant FOLFIRINOX
Condition: Resectable Pancreatic Ductal Adenocarcinoma
Intervention: Drug: FOLFIRINOX
28 Not yet recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
29 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
30 Not yet recruiting A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions: Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
31 Recruiting Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Conditions: Invasive Breast Cancer (Stage I-III);   Ductal Carcinoma in Situ;   Lobular Carcinoma in Situ;   Lobular Carcinoma;   Fatigue Related to Cancer Treatment
Interventions: Drug: Naltrexone;   Drug: Sugar Pill
32 Recruiting Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Condition: Breast Cancer
Intervention: Procedure: contrast-enhanced magnetic resonance imaging
33 Recruiting Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
Conditions: Ductal Carcinoma in Situ - Category;   Breast Cancer;   Prophylactic Mastectomy
Interventions: Procedure: Inframammary Fold Incision or Lateral Radial Incision;   Procedure: Lateral Radial Incision;   Procedure: Inframammary Fold Incision;   Device: Laser-assisted fluorescence angiography
34 Recruiting Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Interventions: Drug: letrozole;   Procedure: MRI;   Procedure: conventional surgery
35 Unknown  Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sorafenib;   Drug: Gemcitabine;   Drug: Cisplatin
36 Recruiting Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Pancreatic Ductal Carcinoma
Interventions: Drug: FOLFIRINOX;   Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Drug: Capecitabine
37 Not yet recruiting Peptide Vaccine in Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
Conditions: Pancreatic Cancer;   Colorectal Cancer
Interventions: Biological: Peptide Vaccine;   Behavioral: Phone Call
38 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Carcinoma Breast Stage IV;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Urinary Bladder Neoplasms;   Cervical Cancer;   Endometrial Cancer;   Follicular Thyroid Cancer;   Glioblastoma Multiforme
Intervention: Drug: IMMU-132
39 Recruiting Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI±biopsy
40 Recruiting Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
Condition: Breast Neoplasms
Intervention: Device: Intraoperative Radiotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years